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The  variable  (V) 1  regions  of  immunoglobulin  light  chains  when  aligned  for 
maximum homology can be divided into four framework regions (FR) separated by 
three complementarity-determining  (CDR)  (hypervariable [1])  regions or segments 
(2, 3). The latter as predicted (1), together with the corresponding three CDR of the 
heavy chain  (4), form the antibody-combining sites (3-11).  Light chains FR1,  FR2, 
FR3, and FR4 comprise residues 1-23, 35-49, 57-88, and 98-107 and CDR1, CDR2, 
and CDR3 residues 24-34, 50-56, and 89-97. If the FR segments were grouped into 
sets of identical sequence and the members of each set were traced, it was shown (12) 
that members of a  given FRI set could be associated with different FR2,  FR3, and 
FR4 sets. This independent assortment suggested that the FR sets, and by implication 
the  CDR  sets,  were  under  different  genetic  control,  and  the  hypothesis  was  put 
forward that the individual FR and CDR sets were controlled by minigenes assembled 
somatically by recombination  at  the  DNA  level  (12).  A  minigene  is  defined  as  a 
segment  of DNA coding  for a  portion  of a  domain  and  which  shows  evidence  of 
segregation as a functional unit independent of the rest of the DNA coding for the V 
region (13). Because we only assorted FR segments, the findings would be independent 
of whether one or two residues of a given CDR assorted with any FR segment. Studies 
by Tonegawa et al. with cloned mouse Vx (14,  15) and V~ (16)  genes and by Seidman 
et  al.  (17,  18)  with  mouse V,  genes  showed  that  in  12-d-old  embryo DNA,  genes 
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coding for residues 1-95 of the V  region were followed by an intervening sequence. 
Other genes for the mouse h-region coded for residues 96-108, termed the J  segment 
and were followed by an intervening sequence of about  1.2 Kb and then by the Cx 
coding segment (15). In mouse V, chains (19, 20), a clone coding for C, contained five 
J  segments, each separated by an intervening sequence that varied in length from 246 
to 310 base pairs and with an intervening sequence of-2.5 Kb between the ol closest 
to C and the C region. Thus, as defined, theJ segments are clearly minigenes (12,  13). 
The amino acid (21) and nucleic acid (22,  23) sequence data on the hinge region 
also show that these nucleotides code only for a  portion of a  domain and therefore 
constitute a minigene. It has been suggested (22, 23) that it evolved from a complete 
domain by a shift of a splice site followed by mutational divergence of the left end of 
the domain to  become a  portion of an  intervening sequence with preservation of 
considerable homology in nucleotide sequence with the 5' flanking end of the CH 1 
domain. 
The  assortment  principle  was  also  used  by Weigert  et  al.  (24)  to  define the ,J 
segment from amino acid sequences with 96 as the site of the recombination, e.g., 
including two residues of CDR3 in ,J. They proposed that some diversity of antibody- 
combining sites  could  be  generated  by  V-J joining because  residue  96  is  highly 
hypervariable (1, 2, 25). Because adult myeloma VL DNA clones code for a contiguous 
stretch of amino acids 1-107 (or 108) (26), the joining oftheJ minigene to the DNA 
of the region coding for amino acids 1-95 has taken place during embryogenesis. 
Because it was subsequently shown (27) that the five clones coding for V~ and the 
three coding for V~ all had segments matching at from 6/7 to 9/10 nucleotides plus 
the Trp codon at position 35, which could serve as recognition sites for recombination 
or insertion of CDR nucleotides between the nucleotides coding for the FR segments 
and for the CDR3-J junction, it was considered of interest to examine the amino acid 
sequences of rabbit V~ chains for evidence of independent assortment of FR and CDR 
segments and to see if a,J segment in the rabbit could be defined by assorting residues 
96 and 97 of CDR3 with FR4 as has been found for the mouse. 
Assorting rabbit V~ sequences may have certain potential advantages in that the 
rabbit populations are not inbred and in that most of the sequencing has been done 
on antibodies with specificities largely limited to several pneumococcal type-specific 
and  to  streptococcal  grot/p-specific  polysaccharides.  It  thus  might  be  possible  to 
recognize assortments associated with or not associated with certain antibody speci- 
ficities in  FR  and CDR  segments.  There  are  also  very many complete rabbit  V~ 
sequences, and yet the degree of sequence variation even among antibodies to the 
same antigen has not made it possible to define individual amino acid residues as 
contacting amino acids. Moreover, the sequence data included one pair of rabbits, 
K9-335 and K9-338, littermates (28, 29) producing monoclonal antibody to strepto- 
coccal group A variant carbohydrate whose light chains were identical in sequence 
from amino acids  1 to  108 and a  second pair of completely unrelated rabbits  (Ch. 
Brandt and ,J. C. olaton. Personal communication.), 311  and 4422, one bred in the 
United States and the other in Switzerland; both had produced monoclonal antibodies 
to  type II pneumococcal polysaccharide whose light chains also were  identical in 
sequence from amino acids 1-108  (30). 
The data provide considerable evidence for independent assortment of FR  and 
CDR segments and, as also concluded by Braun et al. (31), indicate that theJ segment 74  FRAMEWORK AND (2OMPLEMENTARITY-DETERMINING SEGMENTS 
in the rabbit  as in the mouse may include two residues of CDR3  and  may contribute 
to the generation of antibody  diversity. 
Materials  and  Methods 
All  rabbit  V,  sequences  were  contained  in  Sequences of Immunoglobulin Chains (25);  they 
represent the work of numerous groups of investigators and original references may be found in 
(25).  Sequences that  have not been determined  for an entire FR segment were generally not 
used except when an invariant Cys 23 was lacking, and the sequences fell into an FR or CDR 
set  with other members.  All chains with  the identical sequence  for an  FR or CDR  segment 
were grouped together as a set. Members of a set are enclosed in a box. The prototype sequence 
was K4820 and was selected from the set with the most members of FR2, the most commonly 
occurring preserved segment  found  to date  in  1 human  V, IV,  20  mice (6 BALB/c and  14 
NZB),  and  13  rabbit  sequences  (12,  13).  Above the prototype  set  are  listed  all  amino acid 
positions and residues at which the other sets differed from the prototype (32).  Above all other 
sets are listed only the positions and  amino acid residues  at  which the set  differed from the 
prototype. It is thus easy to see which residues in each set differed from the prototype and also 
by comparing any two sets to see at which positions they differ from one another  (32).  If the 
amino acid in any set differed from the prototype at a given position and if this involved a two 
base change, this is indicated by an asterisk (*). If the differences involved deletions or insertions 
or when a three base change was involved this is indicated by a dagger (t"). To define a potential 
J  segment and because of length variations in CDR3, the last  two residues of CDR3 in each 
sequence were renumbered  as 97E and 97F and assorted with FR4 as a J  segment (97E, 97F- 
107) comparable with what had been observed in the mouse by assortment  (24)  and by nucleic 
acid sequencing of clones (26). In rabbit 2717 residue 106A had been misaligned and was made 
residue 107. This homologized all subsequent residues. It should be noted that FR4 is identical 
for all rabbit light chains except for K16-167 in which Thr replaces Gly at position 100. Chains 
that  have  not  been  sequenced  completely  are  given  in  parenthesis  with  the  number  of 
unsequenced positions. Above the sets, unsequenced positions are indicated by a question mark. 
In assembling  Fig.  1,  the  individual  sets  as  typed  were cut out  and  arranged  to  produce  a 
reasonable minimum number of crossing lines in connecting the members of the sets. If this is 
not  done  (24,  33)  patterns  of greater complexity are generally seen  that  do  not  give a  true 
representation of the extent of the assortment. This procedure not only makes for clarity of the 
figures, but  is also essential  conceptually when  there  is  no reason  to arrange  the sets  in any 
specific order. Indeed, when one attempts to rearrange the sets in some defined order to test an 
hypothesis, the finding of increased complexity of the assortment  may provide data consistent 
with or conflicting with the hypothesis. Thus our original simplest assortment  patterns  of FR 
segments of human, mouse, and rabbit V, chains (12) became extremely complex when the sets 
were ordered in terms of the likelihood of the amino acid differences in the FR segments being 
ascribable  to somatic  mutation  (32).  This  increase  in complexity of the assortment  patterns 
indicated that  somatic mutation  was not making a  significant contribution  in generating the 
different FR sets (32). 
All rabbit chains with the prefix K were from breeding colonies at The Rockefeller University 
(New York) and the Basel Institute of Immunology (Basel) and are related. Detailed geneologies 
may be found  in Braun  et  al.  (29,  31);  the prototype  rabbit  K4820  was a  progenitor of the 
Basel colony.  It  and  K4878  and  K4872  came  from  the State  Serum  Institute,  Copenhagen, 
whereas K19, K20, K23 and K31 came from the Rockefeller University colony. Thus a portion 
of the  data  comes  from  families  produced  by  matings  of brother-sister  and  of other  close 
Fro.  1.  Assortment  of FR, (2DR regions, and a proposed J segment of rabbit V, chains. O, antitype 
III pneumococcal polysaccharide;  O, antitype VIII pneumococcal polysaccharide;  A, antistrepto- 
coccal group A variant carbohydrate; &, antistreptococcal group C carbohydrate; x, anti-Micrococcus 
lysodeikticus; +, anti-p-azophenylarsonate;  ~, antitype II pneumococcal polysaccharide;  I--I, antidi- 
goxin; I, anti-p-azobenzoate;  *; two base changes;  t, three base changes;  :~, Gin Gin Asp inserted 
between residues 58 and 59 and Val between 85 and 86; ?, residue not known; -, deletion; ¶, residues 
43 and 44 missing; #, an unidentified residue  is present  at position  97F. K9-335 and K9-338 were 
litter mates.  311  and 4422 are unrelated. One was purchased  from a dealer in the U. S. and the 
other from a dealer in Switzerland. F RX  CD R1 
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relatives, whereas the rest of the data derives from outbred and randomly selected animals. The 
inbred  animals  were  immunized  largely  with  streptococcal group  C  and  group  A  variant 
streptococci, whereas the noninbred animals received pneumococcai polysaccharides, Micrococcus 
lysodeiktieus, etc. 
Results and Discussion 
Table I  presents the findings indicating independent assortment of FR and CDR 
segments and defining a  possible J  segment that contains two residues of CDR3 as 
established earlier in the mouse (19, 20, 24) and as proposed for the rabbit (31). 
Among the important findings are the following: 
(a) The FR sets that contain more than a single member generally show multiple 
antibody specificities. This is true for all FR 1 sets, and for the largest FR2 set. One 
FR2 set with four members and the two FR3 sets containing the pairs of identical 
sequences are limited to a single antibody specificity. 
(b)  The CDR  sets tend to vary. Sets with multiple members in CDR1  have the 
same antibody specificity, whereas the sets in CDR2, the shortest CDR, excluding the 
pairs  with  identical  V-region  sequences,  have  members  with  different  antibody 
specificities.  This  is  perhaps  not  surprising  because  the  antibody  specificities  are 
restricted to but a few antigens and because many members of these sets are related. 
The one CDR3 set of two related members, K16-167 and K27-306 (cousins), but that 
TABLE  I 
Frequency Distribution of Members of Multiple  Sets in Relation to Amount of Sequence Data 
Segment  FRI  CDRI  FR2  CDR2  FR3  CDR3  J 
Amino  acid  residue  1-23  24-34  35-49  50-56  57-88  89-97D 
numbers 
Number of sequences  5l  43  28 (+1")  26  27 (+1")  25  26 
Number of sets  24  34  12 (+3*)  13 (+4*)  26  23  18 
Sets/sequences, %  47  79  43  50  96  92  62 
Sets  with  multiple  11  4  3  4  2  3  4 
members 
Sets with single mere-  13  30  9  9  24  20  14 
bers 
Number of sequences  38  14  21  17  4  4  12 
in sets with multiple 
members 
Number of sequences  75  32  75  65  15  16  46 
in sets with multiple 
members/total 
number  of  se- 
quences, % 
Sets with single mere-  54  85  75  70  88  87  77 
bers/total  number 
of sets, % 
Number of sets/num-  1.05  3.1  0.8  1.8  0.8  1.8  1.5 
bet  of  amino  acid 
residues in segment 
97E, 97F-107 
TheJ segment is made up by taking the last two residues of CDR3, called 97E, 97F, plus FR4 by analogy 
with the mouse J  sequence. 
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differed in  sequence in  the  other FR  and  CDR  segments  had  the same  antibody 
specificity; CDR2 of K27-306 was not sequenced. 
(c) The most striking evidence for independent assortment is the finding that the 
monoclonal antitype II pneumococcal light chains with identical V-region sequence 
from unrelated outbred rabbits 311  and 4422, one from Switzerland, the other from 
the United States (30), had an FR1 identical with two other antistreptococcal group 
A variant antibodies from two other rabbits K16-167 and K27-489. Unlike K16-167 
and K27-489, 311  and 4422 had the preserved FR2 set as did the prototype K4820 
originating in Denmark; this set contained segments of chains of antibodies of three 
specificities different from type II, one chain of no known specificity, as well as two 
other chains with type II specificity. 
(d) The pair of littermates with an identical sequence K9-335 and K9-338 assorted 
in the same set in CDR2 with three related rabbits of the same specificity and with 
three unrelated outbred rabbits 3381, BS-1, and K25--these having another specific- 
ity. It is of interest that a second population of antibodies of the same specificity from 
one  member  of the  pair,  rabbit  K9-335I,  had  different  FR1,  CDRI,  shared  the 
preserved FR2  set,  and  yet was  in  a  CDR2  set  that  contained antibodies  of four 
specificities. 
(e) The J  segment contained 18 sets. This is a large number, especially because the 
FR4 portion, residues 98-107, was identical in all but one sequence, K16-167, which 
had Thr at position  100  instead of Gly. All members of the prototype set had  the 
same specificity as did the set with K16-167, and, indeed, except for this substitution, 
it would have fallen into the prototype J  set because it also has Ile-Val at positions 
97E and  97F.  Of the  three sets with  two members, one set  had  a  chain  3547  not 
known to have antibody activity (34) although it had been immunized with strepto- 
coccal vaccine.  The other had  antistreptococcal group A  variant  activity like the 
prototype set; another set had one chain with antipneumococcal type I!I activity and 
the other with antistreptococcal group A  variant activity; the third set had the two 
identical chains from unrelated rabbits with type II antipneumococcal activity. 
(f) Of the remaining 13 sets of  J  segments that differed from each other and from 
the prototype at one or both of the two positions 97E, 97F which could contribute to 
the  generation  of diversity,  8  were  from  light  chains  of antibodies  to  type  III 
pneumococcal polysaccharide, 2 to p-azobenzoate, and 1 each to type VIII pneumo- 
coccal polysaccharide, to group C streptococcal polysaccharide and to M. lysodeikticus. 
The variations in sequence at positions 97E and 97F for the J  segments from chains 
with  type  III  antipneumococcal  antibody  give  no  indications  of how  they  could 
influence site specificity, but there is no evidence that the different type III sites are 
necessarily the same. 
(g) In me mouse, the first three nucleotides in the intervening sequence following 
the  codon  for  amino  acid  95  are  CCC,  and  there  appears  to  be  considerable 
preservation of nucleotide sequences at the junction of  J  and CDR3  (26). Sakano et 
al. (19), Max et al. (20), and Weigert et al. (24) have proposed that some diversity in 
J  could have been generated by intracodon recombination when the J  nucleotides are 
joined to the rest of the V  region. If one attempts such intracodon recombinations 
assuming CCC  to be preserved at the beginning of the intervening sequence in the 
rabbit as in the mouse, the prototype set Ile Val would generate Leu or Pro at position 
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recombination it would be possible to produce, in addition to Leu and Pro, only His, 
Gin, and Arg, and only Arg has been found at position 97E in one J  segment. Thus 
the amount of diversity that  may be introduced by VJ joining in the rabbit  is not 
very great, and  11 different amino acids have been found at position 97E in the 18 J 
segments. The outbred rabbit may prove, therefore, to have more J, minigenes than 
the inbred mouse  2 or a  more complex mechanism  to generate diversity (35)  as also 
proposed for the variable portion of Ig heavy chain (33). The precise location of the 
N-terminal end of  J  segments cannot be identified from amino acid sequences alone 
(24), and nucleotide sequence data will be needed to determine whether the two last 
amino acid residues in  CDR3  should  indeed be included with  FR4 to form the J 
segments  of rabbit  kappa  light  chains,  as has  been  found  for mouse light  chains. 
Indeed much of the diversity generated by intracodon recombination in the mouse 
derives from an extra Pro between residues 95 and 96 in a  single NZB light chain 
PC7132  (24)  which  was  assigned  to J,  thus  permitting  intracodon recombination 
involving six  nucleotides  of the  intervening sequence  following residues  95.  It  is 
possible that such recombination between the other FR and (2DR minigene segments 
could also contribute somatically to diversity. 
(h)  An  important parameter in relation to any mechanism  for the generation of 
diversity is the number of CDR and J  sets in relation to FR sets. Table I is an attempt 
to estimate this.  If there are many more CDR  sets than  FR  sets,  this would  have 
substantial  implications for the generation of diversity. Although the rabbit  amino 
acid sequence data are the most extensive, they nevertheless represent a  very highly 
selected group of sequences because of the limited number of antibody specificities 
that  have been examined. The data are also skewed in  that  many more FRI  and 
CDR1 sequences have been determined as compared with the rest of the chain. The 
tendency to have multiple sets will also be a  function of the length of each segment 
comprising the set. Table I attempts to obtain an estimate of the relative numbers of 
FR and CDR sets. 
If the CDR  are compared with the FR, it is clear, as seen from the last  row in 
Table I, that the number of sets is a function of the number of amino acid residues in 
the FR or CDR  segment, and this must  be taken into account.  Even without  this, 
however, it is clear comparing FR 1 and FR2 with CDR 1 that there are almost twice 
as many sets in CDR1 as in FR1 and FR2 and that a much smaller proportion of sets 
in  CDRI  has  multiple  members  despite  the  selection  for  only  a  few  antibody 
specificities. If these values are corrected for length of the segment, the difference in 
number of sets between (]DR ] relative to FR 1 and FR2 increases two to three times. 
The same results are seen if CDR3 and the proposed J  segment are compared with 
FRI  and  FR2;  in each instance,  the percentage of sequences in sets with multiple 
members is much lower for CDR3 and J. These differences in number of sets would 
be  further  increased  if adjusted  for  length  differences with  CDR2,  which  differs 
strikingly in length from the other segments and which shows much less variability in 
rabbit V, chains than is seen in other species (36). The proportion of sequences in sets 
2 Rudikoff, S., D. M. Rao, C. P. J. Glaudemans, and M. Potter (personal communication) have suggested 
for mouse antigalactan Vx light chains that an additional gene containing an A as the first nucleotide of 
the intervening sequence following the codon for amino acid  95  could also account  for the additional 
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with multiple members is less than in FR 1 and FR2. The number of sets would also 
almost be doubled if adjusted for length differences. 
(i) The data on FR3, the segment of longest length, do not appear to fit with the 
other segments. The 26 sets each have but  a  single sequence except the 2 sets each 
with the completely identical V~ chains. However, there is some indication that FR3 
can  be  divided  into  two  segments  which  show  some  suggestion  of assortment  or 
recombination.  Such assortment can be seen if F'R3 is separated into two segments 
57-68 and 69-88;  the data are generally similar for 57-69 and  70-88 or 57-70 and 
71-88.  Fig.  2  shows  the  data  for  57-68  and  60-88;  it  is  clear  that  many of the 
individual chains in Fig.  1 can be grouped into sets and that these sets show evidence 
of assortment.  It  may  be  of significance  that  the  three-dimensional  structure  of 
immunoglobulin light chains shows residues 68 and 60 to be at a  bend connecting 
two//-strands in the mouse V, light chain Fv dimer REI (5, 9). 
The two sets of .57-68 contain  13 and 5  chains  and  assort with six sets of 60-88 
containing two or three members each. Thus the separation of FR3 into two segments 
has substantially reduced the 26 distinct FR3 sets. 
Although the clones from  12-d-old mouse embryo DNA indicate that nucleotides 
coding  for  amino  acids  1-05  occur  as  a  contiguous  segment  (14,  17,  18,  26),  the 
evidence for assortment, by recombination with or insertion into nucleotides coding 
for FR segments, of nucleotides coding for CDR segments suggests that this minigene 
mechanism in addition to diversity generated by the joining of residues 1-95 to the J 
minigene is fundamental to the generation of diversity. 
57-68 
59Pro 
K482o  | 
K9-335 F  ' 
IK9-338 | 
i  K29-213  1 
IBS-5  ) 
3547  l 
)311  l  14422 
,K16-167  | 
K49-501 I--'-- 
3322-B 
,K30-3671  \ 
B4B5  J  '~ 
59Ser 
69-88 
70Gin 78Val 
74Pro 79Gin 
77Asp 81Ala 
'~  74Thr 
~~  lK732"50J 
70Glu 77Gly 
74Thr 81Asp 
78Leu 79Glu 
" 
70Glu 79Glu 
78Leu 
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The recent report of Schilling et al. (33) of a segment generating diversity in CDR3 
N-terminal  to  the J  segment  of anti-al  ---*  3  dextran  hybridomas  and  bearing 
individual idiotypic determinants provides additional evidence consistent with the 
minigene hypothesis. 
It is important to distinguish between the generation of diversity and the generation 
of complementarity differences responsible for antibody specificity, e.g., for noncova- 
lent binding of an antigenic determinant in the antibody-combining site. Although 
positions 96 and 97 of CDR3 of VL are coded for by the J  minigenes (195 20)  and 
although position 96 shows the highest variability (1,  2,  25),  position 96 has been 
identified only once as a  contacting residue in the high resolution x-ray crystallo- 
graphic structures thus far reported (5-11)  and in initial model building studies of 
antibody-combining sites without (37,  38)  or with (39)  nuclear magnetic resonance 
data in which the amino acid residues of the CDR sequences known to bind ligands 
were  introduced on  to  a  framework established  by x-ray crystallographic studies. 
Padlan et al. (40) established residue 96 as a contacting residue for phosphorylcholine 
in the mouse myeloma protein McPC603. In mouse V, chains position 97 is essentially 
invariant  (25).  Rudikoff et  al.  ~ also  consider  that  in  the  fll  ---* 6  galactans,  the 
alternative amino acids at position 96 do not contribute to complementarity. Thus 
the intracodon recombination proposed (19, 20, 24) as a  mechanism for V-J joining 
and for reducing the number ofJ minigenes might create sequence diversity without 
contributing significantly to those complementarity differences which would make 
for various antibody specificities. Indeed, even if antibody site complementarity were 
to  be  generated  by  position  96  as  in  McPC603  when  an  actual J  sequence  was 
assembled somatically by joining to the rest of the V region, it would not necessarily 
follow that the other amino acids if  created at position 96 by intracodon recombination 
would necessarily function as  CDR  residues  in  CDR3  although conceivably they 
might  influence  other  residues  in  CDR3  conformationally so  that  they  become 
contacting. Indeed, although the discovery of the J  minigene and of somatic assembly 
at the DNA level between the 12th d of embryonic life and the adult (12,  15, 17, 18, 
26) is a seminal development in molecular genetics, it has tended to focus attention 
on  position  96  and  away  from  the  other  CDR  residues  that  are  crucial  to  the 
generation of antibody diversity, of idiotypic specificity, and of their interrelations. 
Summary 
Amino acid sequences of rabbit  light chains "show considerable evidence of inde- 
pendent  assortment of framework  (FR)  and  complementarity-determining (CDR) 
segments. This suggests that they are coded for by independent genetic units (mini- 
genes)  and that  individual light chains are assembled somatically by recombining 
these units. Identical FR sets with multiple members generally comprise chains with 
different specificities, whereas  identical CDR  sets  tend to  have chains of a  single 
specificity. AJ segment, which, by analogy with mouse light chains, is made up of the 
last  two residues of CDR3  plus  all of FR4, contained  18  different sets and could 
contribute to diversity generated by CDR3. 
The longest segment, FR3, had a very large number of sets.  Evidence is presented 
showing that the number of sets could be substantially reduced by permitting FR3 to 82  FRAMEWORK AND COMPLEMENTARITY-DETERMINING SEGMENTS 
be formed by two independently  assorting segments comprising residues  57-68 and 
69-88. 
Received  for publication 22 February 1980. 
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